Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China’s Coronavirus Vaccine Ambition Hampered By Lack Of Guidance On Overseas Clinical Data

As two Chinese-developed vaccines against COVID-19 enter the final stage of testing in Latin America and the Middle East, a lack of guidance on using data obtained outside China could potentially pose challenges to regulatory approvals at home.

Vaccines Coronavirus COVID-19 Clinical Trials

China Provides Patent Linkage In Latest Law Draft - Why Now?

In a significant development, China proposes to strengthen the protection of new drugs through not only patent linkage but also patent compensation in the latest draft of its revised Patent Law.

Intellectual Property China Legislation

China Turns COVID-19 Crisis Into A Global Health Care Opportunity

Another important step has been taken under the Healthy China initiative, with the implementation on June 1 of a basic law on access to health care. This provides additional tailwind for a health system that appeared to efficiently contain its coronavirus outbreak and is now making further structural improvements.

Market Intelligence Medical Device China
UsernamePublicRestriction

Register